2,3-dimethylmaleic anhydride has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Li, XX; Ma, JB; Shen, JM; Zhang, SQ; Zhu, ZY; Zhuang, R | 1 |
1 other study(ies) available for 2,3-dimethylmaleic anhydride and Liver Neoplasms
Article | Year |
---|---|
pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
Topics: Animals; Antibiotics, Antineoplastic; Cell-Penetrating Peptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Male; Maleic Anhydrides; Mice; Nanoparticles; Nanotechnology; Peptide Fragments; Polyethylene Glycols; Polylysine; tat Gene Products, Human Immunodeficiency Virus; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden | 2018 |